![Simeon George](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Simeon George
Directeur/Membre du Conseil chez
DESIGN THERAPEUTICS, INC.
Fortune : 210 $ au 31/05/2026
Profil
Simeon J.
George was the founder of Nkarta, Inc., founded in 2015, where the title held was Independent Director from 2015 to 2017.
Dr. George is the founder of SR One Capital Management LP, founded in 2020, holding the title of CEO & Managing Partner since 2020.
Current jobs included Chief Executive Officer at GSK Equity Investments Ltd. since 2007; Director at Bird Rock Bio Sub, Inc. since 2009; Director at Auxogyn, Inc.; Director at eFFECTOR Therapeutics Operations, Inc. since 2013; Independent Director at CRISPR Therapeutics AG since 2015; Director at Battersea Biotech, LLC; Lead Independent Director at Design Therapeutics, Inc. since 2023; Director at Simcha Therapeutics, Inc.; Director at Rezo Therapeutics, Inc.; and Independent Director at Nkarta, Inc. since 2020.
Former jobs include Independent Director at HTG Molecular Diagnostics, Inc. from 2011 to 2015; Independent Director at Genocea Biosciences, Inc. from 2013 to 2014; Director at Semprus BioSciences Corp.
from 2010 to 2012; Independent Director at Principia Biopharma, Inc. from 2011 to 2020; Independent Non-Executive Director at Turning Point Therapeutics, Inc. from 2017 to 2022; Director at Progyny, Inc. from 2012 to 2019; Director at Simcha Therapeutics Holding Co. LLC; Principal at Merrill Lynch & Co., Inc.; and Associate at Goldman Sachs & Co. LLC.
Education includes undergraduate degree from The Johns Hopkins University, MBA from The Wharton School of the University of Pennsylvania, and doctorate from the University of Pennsylvania Medical Center.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2026 | 20 ( 0 % ) | 210 $ | 31/05/2026 | |
NKARTA, INC. -.--% | 17/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| 31/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Simeon George
| Sociétés | Poste | Début |
|---|---|---|
| CRISPR THERAPEUTICS AG | Directeur/Membre du Conseil | 29/04/2015 |
| DESIGN THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/02/2020 |
| NKARTA, INC. | Directeur/Membre du Conseil | 01/02/2020 |
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity invests in companies located in the United States and United kingdom. The firm targets companies operating in the field of biotechnology sector. It provides financing for early stage capital requirements. | Directeur Général | 01/01/2007 |
Rezo Therapeutics, Inc.
 Rezo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Identifies targets and therapies by combining distinct, unbiased technologies with artificial intelligence | Directeur/Membre du Conseil | - |
Simcha Therapeutics, Inc.
 Simcha Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops novel immunotherapies for cancer | Directeur/Membre du Conseil | - |
SR One Capital Management LP
 SR One Capital Management LP Investment ManagersFinance SR One invests in companies located in the United States and the United kingdom. The firm focuses on the biotechnology sector. It provides financing for early stage capital requirements. | Directeur Général | 01/01/2020 |
Battersea Biotech, LLC
 Battersea Biotech, LLC Pharmaceuticals: MajorHealth Technology Develops cell therapies for treating cancer | Directeur/Membre du Conseil | - |
eFFECTOR Therapeutics Operations, Inc.
 eFFECTOR Therapeutics Operations, Inc. BiotechnologyHealth Technology Operates a clinical-stage biopharmaceutical company that develops oncology drugs | Directeur/Membre du Conseil | 01/05/2013 |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░ ░░░░ ░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Simeon George
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Simeon George
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
55
Relations au 1er degré
23
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 23 |
|---|---|
Merrill Lynch & Co., Inc. /Old/
 Merrill Lynch & Co., Inc. /Old/ Investment Banks/BrokersFinance Provides wealth management, securities trading and sales, corporate finance and investment banking services | Finance |
HTG Molecular Diagnostics, Inc.
 HTG Molecular Diagnostics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides molecular technology solutions | Commercial Services |
Genocea Biosciences, Inc.
 Genocea Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that discovers and develops novel cancer immunotherapies | Health Technology |
Semprus BioSciences Corp.
 Semprus BioSciences Corp. Pharmaceuticals: GenericHealth Technology Develops medical devices for anti-microbial coating to reduce bloodstream infections | Health Technology |
Principia Biopharma, Inc.
 Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a R&D driven and AI-powered biopharma company | Health Technology |
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage structure-based drug design company for discovery and development of precision medicines for cancer and other diseases | Health Technology |
GSK Equity Investments Ltd.
GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity invests in companies located in the United States and United kingdom. The firm targets companies operating in the field of biotechnology sector. It provides financing for early stage capital requirements. | Finance |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bird Rock Bio Sub, Inc.
 Bird Rock Bio Sub, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Auxogyn, Inc.
 Auxogyn, Inc. BiotechnologyHealth Technology Provides novel scientific and development biotechnology services | Health Technology |
eFFECTOR Therapeutics Operations, Inc.
eFFECTOR Therapeutics Operations, Inc. BiotechnologyHealth Technology Operates a clinical-stage biopharmaceutical company that develops oncology drugs | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CRISPR Therapeutics AG
 CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
University of Pennsylvania Medical Center
 University of Pennsylvania Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Progyny, Inc.
 Progyny, Inc. Miscellaneous Commercial ServicesCommercial Services Provides fertility and family building benefits solutions | Commercial Services |
Nkarta, Inc.
 Nkarta, Inc. BiotechnologyHealth Technology Discovers, develops and delivers NK cell therapies for cancer treatment | Health Technology |
Battersea Biotech, LLC
Battersea Biotech, LLC Pharmaceuticals: MajorHealth Technology Develops cell therapies for treating cancer | Health Technology |
Simcha Therapeutics Holding Co. LLC
 Simcha Therapeutics Holding Co. LLC BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Design Therapeutics, Inc.
 Design Therapeutics, Inc. BiotechnologyHealth Technology Operates biotechnology company that develops therapies for serious degenerative disorders | Health Technology |
Simcha Therapeutics, Inc.
Simcha Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops novel immunotherapies for cancer | Health Technology |
SR One Capital Management LP
SR One Capital Management LP Investment ManagersFinance SR One invests in companies located in the United States and the United kingdom. The firm focuses on the biotechnology sector. It provides financing for early stage capital requirements. | Finance |
Rezo Therapeutics, Inc.
Rezo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Identifies targets and therapies by combining distinct, unbiased technologies with artificial intelligence | Commercial Services |
